Physician profile
Regina Hill
NPI 1467441501
$18,437.05
in general payments reported to CMS, 2019-2025
41 companies · $10K in 2025
The $10K reported for 2025 was more than what 99% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $983 · 2020: $1,089 · 2021: $2,764 · 2022: $1,556 · 2023: $1,159 · 2024: $608 · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $9,886 · Food and Beverage: $2,159.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $9,886.07 |
| Food and Beverage | $2,159.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $9,902.80 | 2020-2025 | Luminelle Dtx Hysteroscopy System |
| Axonics, INC. | $2,188.73 | 2020-2023 | Axonics, Bulkamid |
| Abbvie INC. | $1,416.94 | 2019-2023 | |
| Pfizer INC. | $552.45 | 2019-2024 | |
| Currax Pharmaceuticals LLC | $529.27 | 2020-2024 | Contrave |
| Allergan, INC. | $379.51 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $344.30 | 2023-2025 | Myfembree, Gemtesa |
| Mayne Pharma Commercial LLC | $327.92 | 2021-2025 | |
| Therapeuticsmd, INC. | $316.67 | 2019-2022 | |
| Myovant Sciences INC. | $289.60 | 2021-2022 | |
| Astellas Pharma US INC | $255.80 | 2019-2025 | Veozah, Myrbetriq |
| Coloplast Corp | $238.64 | 2019 | |
| Novo Nordisk INC | $210.70 | 2019-2024 | Wegovy |
| Agile Therapeutics, INC. | $168.94 | 2021-2024 | Twirla |
| Gynesonics, INC. | $137.88 | 2022 |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lupin INC. | $132.55 | 2020-2021 | |
| Avion Pharmaceuticals | $116.65 | 2019-2023 | Balcoltra |
| Organon LLC | $112.64 | 2021-2025 | Nexplanon |
| Millicent US INC | $112.16 | 2021-2025 | Intrarosa, Femring, Femlyv |
| Channel Medsystems, INC. | $111.55 | 2022 | |
| Lilly USA, LLC | $65.16 | 2024-2025 | Zepbound, Jardiance |
| Hologic Sales and Service, LLC | $53.82 | 2019-2022 | |
| Dysis Medical, INC. | $45.21 | 2021-2023 | Dysis View, Dysis Ultra 2.0, Dysis V3 Digital Coploscope |
| Exact Sciences Corporation | $43.26 | 2025 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $41.79 | 2019-2022 | |
| Boston Scientific Corporation | $41.22 | 2019-2025 | Axonics |
| Amag Pharmaceuticals, INC. | $37.85 | 2019 | |
| Aspira Women'S Health INC | $35.87 | 2022 | |
| Scynexis, INC. | $32.85 | 2022 | |
| Medtronic, INC. | $26.50 | 2024 | Interstim |
| Caldera Medical, INC | $21.30 | 2022 | |
| Novartis Pharmaceuticals Corporation | $19.95 | 2020 | |
| Galderma Laboratories, L.P. | $16.47 | 2021 | |
| Smith+Nephew, INC. | $16.45 | 2021 | |
| Roche Diagnostics Corporation | $15.93 | 2019 | |
| Applied Medical Technology INC | $15.14 | 2025 | |
| Hologic INC | $14.29 | 2021 | |
| Minerva Surgical, INC | $13.50 | 2020 | |
| Medtronic USA, INC. | $13.50 | 2020 | |
| Duchesnay USA Incorporated | $11.16 | 2019 | |
| Meditrina | $10.13 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Regina Hill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.